Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Two-Session education program ease stress in High-Risk pregnancies?

NCT ID NCT07820306

Symptom relief Sponsor: Istanbul University - Cerrahpasa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers are testing whether a structured prenatal education program based on the Roy Adaptation Model can reduce stress and improve quality of life for pregnant women with hypertensive disorders. The study enrolls 54 pregnant women between 20 and 32 weeks of gestation who have been diagnosed with a hypertensive disorder of pregnancy. Participants are randomly assigned to either receive two face-to-face education sessions one week apart or receive routine antenatal care. The education covers blood pressure monitoring, healthy lifestyle habits, stress management, and adapting to physical and emotional changes during pregnancy. Researchers measure perceived stress and pregnancy-related quality of life before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Roy Adaptation Model-based prenatal education, a structured two-session face-to-face program
What this could lead to
If it works, this could give pregnant women with high blood pressure a low-risk, non-drug way to manage stress and feel better during pregnancy.
What could go wrong
The trial is small and measures stress and quality of life through questionnaires, so results may reflect how women feel rather than hard health outcomes. Education alone may not be enough for women with severe hypertension.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 54 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women who apply to the antenatal outpatient clinic of the relevant hospital. * Women diagnosed by a physician with a hypertensive disorder of pregnancy. Women who are between 20 and 32 weeks of gestation. * Women aged 18 years or older. * Primiparous or multiparous pregnant women. * Women who can read and understand Turkish and communicate in Turkish. * Women who are willing to participate in the study. Exclusion Criteria: * Pregnant women with severe preeclampsia, eclampsia, HELLP syndrome, or a clinical condition requiring emergency obstetric intervention. * Pregnant women who are hospitalized or scheduled for hospitalization at the beginning of the study. * Pregnant women diagnosed with fetal anomaly or intrauterine fetal death. * Pregnant women with severe psychiatric, neurological, or cognitive impairment that may prevent participation in the education sessions or completion of the data collection instruments. * Pregnant women who develop a serious obstetric or clinical complication during the study that may affect the primary outcomes of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertensive disorders of pregnancy (HDP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertensive disorders of pregnancy (HDP)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi

    Istanbul, 34384, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.